Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 4
2012 3
2013 3
2014 4
2015 4
2016 2
2017 2
2018 12
2019 12
2020 21
2021 20
2022 25
2023 21
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Coffee and cancer risk: a summary overview.
Alicandro G, Tavani A, La Vecchia C. Alicandro G, et al. Eur J Cancer Prev. 2017 Sep;26(5):424-432. doi: 10.1097/CEJ.0000000000000341. Eur J Cancer Prev. 2017. PMID: 28288025 Review.
Challenges with optimizing nutrition in cystic fibrosis.
Colombo C, Nobili RM, Alicandro G. Colombo C, et al. Among authors: alicandro g. Expert Rev Respir Med. 2019 Jun;13(6):533-544. doi: 10.1080/17476348.2019.1614917. Epub 2019 May 16. Expert Rev Respir Med. 2019. PMID: 31094240 Review.
Laboratory medicine: health evaluation in elite athletes.
Lombardo B, Izzo V, Terracciano D, Ranieri A, Mazzaccara C, Fimiani F, Cesaro A, Gentile L, Leggiero E, Pero R, Izzo B, D'Alicandro AC, Ercolini D, D'Alicandro G, Frisso G, Pastore L, Calabrò P, Scudiero O. Lombardo B, et al. Among authors: d alicandro g. Clin Chem Lab Med. 2019 Sep 25;57(10):1450-1473. doi: 10.1515/cclm-2018-1107. Clin Chem Lab Med. 2019. PMID: 30835249 Free article. Review.
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis.
Gramegna A, Misuraca S, Lombardi A, Premuda C, Barone I, Ori M, Amati F, Retucci M, Nazzari E, Alicandro G, Ferrarese M, Codecasa L, Bandera A, Aliberti S, Daccò V, Blasi F. Gramegna A, et al. Among authors: alicandro g. Respir Res. 2023 Dec 16;24(1):316. doi: 10.1186/s12931-023-02612-1. Respir Res. 2023. PMID: 38104098 Free PMC article. Review.
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes.
Grancini V, Gramegna A, Zazzeron L, Alicandro G, Porcaro LL, Piedepalumbo F, Lanfranchi C, Daccò V, Orsi E, Blasi F. Grancini V, et al. Among authors: alicandro g. Diabetes Metab. 2023 Sep;49(5):101466. doi: 10.1016/j.diabet.2023.101466. Epub 2023 Aug 1. Diabetes Metab. 2023. PMID: 37536552
126 results